BioStem Technologies, Inc.: valuation
BSEMNASDAQHealthcare · Biological Products, (No Diagnostic Substances)New listingsince Aug 6, 2026
Price
$1.05
November 13, 2026Market cap $20M
New listing: quarterly reports only so far
The first annual report (10-K) is expected around March 31, 2027; valuation and multi-year figures start then.